Online consultations in general practice: the questions to ask – Royal College of General Practitioners

This guidance provides patients, GPs and commissioners with a list of questions to consider before using or utilising online general practice services. It urges CCGs to consider whether online consultation systems are likely to address current demand or generate new demand,

Drug misuse prevention: Quality standard [QS165] – NICE

This quality standard covers the prevention or delay of harmful use of drugs by children, young people and adults most likely to start using drugs, or already experimenting or using drugs occasionally. This includes illegal psychoactive substances, solvents, volatile substances,

The state of care in independent online primary health services: Findings from CQC’s programme of comprehensive inspections in England – Care Quality Commission

Delivering primary health care online is a growing and evolving area, the inspections undertaken highlighted variation in quality, with the most  important areas for improvement around the safety and effectiveness of care and treatment, in particular relating to: safe prescribing

ODESSA: Optimising care delivery models to support ageing-in-place – University of Sheffield

Brings together international research findings on current long-term care delivery models for older people and assesses the key factors that allow them to live independently for longer.  It reports on a  three-year project investigated new and innovative ways of adapting a

Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C: Technology appraisal guidance [TA507] – NICE

Evidence-based recommendations on sofosbuvir–velpatasvir–voxilaprevir (Vosevi) for treating chronic hepatitis C in adults.

PleurX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites: Medical technologies guidance [MTG9] – NICE

Updated evidence-based recommendations on PleurX for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites. This guidance has been updated to include a review of the cost model using more recent values. New evidence and updated costs identified during the guidance review

MiraQ for assessing graft flow during coronary artery bypass graft surgery: Medical technologies guidance [MTG8] – NICE

Evidence-based recommendations on MiraQ for assessing graft flow during coronary artery bypass graft surgery. Having originally been developed to make recommendations on the use of VeriQ, this guidance has been updated to make recommendations on the use of a follow-on

Reveal LINQ insertable cardiac monitor to detect atrial fibrillation after cryptogenic stroke: Medtech innovation briefing [MIB141] – NICE

The technology described in this briefing is Reveal LINQ insertable cardiac monitor (ICM) with CareLink service for detecting suspected asymptomatic atrial fibrillation (AF) after cryptogenic stroke. The innovative aspects are: a proprietary AF detection algorithm, which is designed to reduce false positive detections; small

Coban 2 for venous leg ulcers: Medtech innovation briefing [MIB140] – NICE

Medical innovation bulletin on Coban 2 compression bandage for venous leg ulcers. The innovative aspect is that it is thinner than 4‑layer bandages. This aims to improve mobility and convenience. The intended place in therapy would be as an alternative to current compression bandages in

Raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women: Technology appraisal guidance [TA160] – NICE

Evidence-based recommendations on raloxifene for the primary prevention of osteoporotic fragility fractures in postmenopausal women.

Raloxifene and teriparatide for the secondary prevention of osteoporotic fragility fractures in postmenopausal women: Technology appraisal guidance [TA161] – NICE

Evidence-based recommendations on raloxifene and teriparatide for preventing osteoporotic fragility fractures in postmenopausal women who have osteoporosis.

Bisphosphonates for treating osteoporosis: Technology appraisal guidance [TA464] – NICE

Evidence-based recommendations on the bisphosphonates alendronic acid, ibandronic acid, risedronate sodium and zoledronic acid for treating osteoporosis.

Ibrutinib for treating relapsed or refractory mantle cell lymphoma: Technology appraisal guidance [TA502] – NICE

Evidence-based recommendations on ibrutinib (Imbruvica) for treating relapsed or refractory mantle cell lymphoma in adults.

Fulvestrant for untreated locally advanced or metastatic oestrogen-receptor positive breast cancer: Technology appraisal guidance [TA503] – NICE

Evidence-based recommendations on fulvestrant (Faslodex) for treating locally advanced or metastatic (secondary), oestrogen-receptor positive breast cancer in postmenopausal women who have not had endocrine therapy before.

Ixazomib with lenalidomide and dexamethasone for treating relapsed or refractory multiple myeloma: Technology appraisal guidance [TA505] – NICE

Evidence-based recommendations on ixazomib (Ninlaro) with lenalidomide and dexamethasone for relapsed or refractory multiple myeloma in adults.

Lesinurad for treating chronic hyperuricaemia in people with gout: Technology appraisal guidance [TA506] – NICE

Evidence-based recommendations on lesinurad (Zurampic) for treating chronic hyperuricaemia in adults with gout.

Golimumab for treating non-radiographic axial spondyloarthritis: Technology appraisal guidance [TA497] – NICE

Evidence-based recommendations on golimumab (Simponi) for severe non-radiographic axial spondyloarthritis. This drug is for adults who have tried nonsteroidal anti-inflammatory drugs (NSAIDs), but they have not worked. Golimumab is recommended, within its marketing authorisation, as an option for treating severe non-radiographic axial

TYM smartphone otoscope for imaging and videoing the external ear canal and eardrum: Medtech innovation briefing [MIB134] – NICE

The TYM smartphone otoscope (Cupris) uses an iOS smartphone to let users capture images and videos of the external ear canal and eardrum. These can then be reviewed and shared securely with other healthcare professionals through the Cupris app.  The TYM smartphone otoscope